Early biomarkers of Williams-Beuren syndrome: a preclinical study in the CD mouse model

dc.contributor.authorGiannoccaro, Silvia
dc.contributor.authorFerraguto, Celeste
dc.contributor.authorPetroni, Valeria
dc.contributor.authorMarcelly, Coline
dc.contributor.authorNogues, Xavier
dc.contributor.authorCampuzano Uceda, María Victoria
dc.contributor.authorPietropaolo, Susanna
dc.date.accessioned2023-01-25T17:15:55Z
dc.date.available2023-01-25T17:15:55Z
dc.date.issued2023-01-21
dc.date.updated2023-01-25T17:15:55Z
dc.description.abstractWilliams-Beuren syndrome (WBS) is a neurodevelopmental disorder caused by a chromosomic microdeletion (7q11.23). WBS has been modeled by a mouse line having a complete deletion (CD) of the equivalent mouse locus. This model has been largely used to investigate the etiopathological mechanisms of WBS, although pharmacological therapies have not been identified yet. Surprisingly, CD mice were so far mainly tested in adulthood, despite the developmental nature of WBS and the critical relevance of early timing for potential treatments. Here we provide for the first time a phenotypic characterization of CD mice of both sexes during infancy and adolescence, i.e., between birth and 7 weeks of age. CD pups of both sexes showed reduced body growth, delayed sensory development, and altered patterns of ultrasonic vocalizations and exploratory behaviors. Adolescent CD mice showed reduced locomotion and acoustic startle response, and altered social interaction and communication, the latter being more pronounced in female mice. Juvenile CD mutants of both sexes also displayed reduced brain weight, cortical and hippocampal dendritic length, and spine density. Our findings highlight the critical relevance of early neurobehavioral alterations as biomarkers of WBS pathology, underlying the importance of adolescence for identifying novel therapeutic targets for this neurological disorder.
dc.format.extent20 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec728440
dc.identifier.issn2073-4409
dc.identifier.urihttps://hdl.handle.net/2445/192615
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/cells12030391
dc.relation.ispartofCells, 2023, vol. 12, p. 391
dc.relation.urihttps://doi.org/10.3390/cells12030391
dc.rightscc-by (c) Giannoccaro, Silvia et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Biomedicina)
dc.subject.classificationSíndrome de Williams
dc.subject.classificationMalalties mentals
dc.subject.classificationMarcadors bioquímics
dc.subject.classificationTrastorns de la conducta
dc.subject.classificationProducció de sons pels animals
dc.subject.classificationRatolins (Animals de laboratori)
dc.subject.classificationAdolescència
dc.subject.otherWilliams syndrome
dc.subject.otherMental illness
dc.subject.otherBiochemical markers
dc.subject.otherBehavior disorders
dc.subject.otherSound production by animals
dc.subject.otherMice (Laboratory animals)
dc.subject.otherAdolescence
dc.titleEarly biomarkers of Williams-Beuren syndrome: a preclinical study in the CD mouse model
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
728440.pdf
Mida:
10.31 MB
Format:
Adobe Portable Document Format